Effect of glutathione S‐transferase genetic polymorphisms on busulfan pharmacokinetics and veno‐occlusive disease in hematopoietic stem cell transplantation: A meta‐analysis-Reference-Cited by-同舟云学术

Effect of glutathione S‐transferase genetic polymorphisms on busulfan pharmacokinetics and veno‐occlusive disease in hematopoietic stem cell transplantation: A meta‐analysis

Published:2018-12-25 Issue:6 Volume:124 Page:691-703
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharmacol Toxicol

Author:

Kim Myeong Gyu¹,Kwak Arim²,Choi Boyoon³,Ji Eunhee⁴,Oh Jung Mi³,Kim Kyungim²

Affiliation:

1. Graduate School of Clinical Pharmacy CHA University Pocheon Korea

2. College of Pharmacy Korea University Sejong Korea

3. College of Pharmacy and Research Institute of Pharmaceutical Sciences Seoul National University Seoul Korea

4. Research Institute of Pharmaceutical Sciences College of Pharmacy Gachon University Incheon Korea

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcpt.13185

Reference47 articles.

1. Association of busulfan area under the curve with veno‐occlusive disease following BMT;Dix SP;Bone Marrow Transplant,1996

2. Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantation

3. Graft‐rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics;Slattery JT;Bone Marrow Transplant,1995

4. An evaluation of engraftment, toxicity and busulfan concentration in children receiving bone marrow transplantation for leukemia or genetic disease

5. Busulfan systemic exposure relative to regimen-related toxicity and acute graft-versus-host disease: Defining a therapeutic window for i.v. BuCy2 in chronic myelogenous leukemia

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Susceptibility in Endothelial Injury Syndromes after Hematopoietic Cell Transplantation and Other Cellular Therapies: Climbing a Steep Hill;Current Issues in Molecular Biology;2024-05-15

2. Pharmacokinetic Modeling and Simulation with Pharmacogenetic Insights Support the Relevance of Therapeutic Drug Monitoring for Myeloablative Busulfan Dosing in Adult HSCT;Transplantation and Cellular Therapy;2023-12

3. Busulfan induces steatosis in HepaRG cells but not in primary human hepatocytes: Possible explanations and implication for the prediction of drug‐induced liver injury;Fundamental & Clinical Pharmacology;2023-09-04

4. Pharmacogenomics in allogeneic hematopoietic stem cell transplantation: Implications on supportive therapies and conditioning regimens;Best Practice & Research Clinical Haematology;2023-06

5. Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan;Bone Marrow Transplantation;2023-04-21